DOCSLIB.ORG

Annual Meeting Program

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Meeting Program FIRENZE FIERA CONGRESS & EXHIBITION CENTER FLORENCE, ITALY MARCH 8-11, 2017 PROGRAM WWW.SRNT.ORG SRNT 2017 · Florence, Italy TABLE OF CONTENTS Abstract Reviewers . 8 Badges ........................................... 16 Board of Directors . 17 Conference Safety Rules and Guidelines . 18 Continuing Education Credits .......................... 14 Educational Objectives................................ 13 Exhibitors .......................................... 24 Evaluation.......................................... 16 Future Meetings ..................................... 18 Meeting Room Floor Plans ............................ 25 Index–Author ....................................... 93 Internet Access ..................................... 13 Lunches ........................................... 14 Meet-the-Editor Sessions ............................. 17 Message from the Program Chair ........................ 3 Members Meetings .................................. 16 Network Advisory Committee ............................ 7 Past Presidents and Program Chairs . 11 Poster Session Setup Schedule ........................ 15 Program Committee . 6 Registration ........................................ 13 Remembrances of Pioneers for Whom SRNT’s 2017 Awards Are Named .............................. 19 Schedule-at-a-Glance . 107 Session Summary: Wednesday, March 8, 2017 .......................... 29 Thursday, March 9, 2017 ........................... 41 Friday, March 10, 2017 ............................. 59 Saturday, March 11, 2017 ........................... 77 Speaker Ready Room ................................ 16 SRNT Supporters . 13 Target Audience ..................................... 13 1 SRNT 2017 · Florence, Italy 2 SRNT 2017 · Florence, Italy MESSAGE FROM THE PROGRAM CHAIR Dear Colleagues, On behalf of the SRNT Program Committee, we welcome you to the 23rd Annual Meeting of the Society for Research on Nicotine and Tobacco (SRNT), in the wonderful city of Florence! As always the meeting offers you a transdisciplinary collection of cutting-edge science across the full spectrum of basic and applied research on nicotine and tobacco. This year there will be presen- tations on a number of pivotal clinical trials, plus hot topics in the field of tobacco use epidemiology, genomics, biomarkers, cue reactivity, e-cigarettes, cigar use, waterpipes, smokeless tobacco, secondhand exposure, and tobacco product regulation. However, you will notice this year that there is a strong focus on concurrent use of tobacco with other psychoactive substances and drugs. We will discuss findings from basic science, pre-clinical and clinical studies to understand complex interactions between nicotine and other substances. Whilst the overall prevalence of smoking is decreasing in many countries, a significant proportion of tobacco smokers also use various psychoactive substances. Also, smoking rates are high among those who are addicted to various legal and illegal drugs, including marijuana, alcohol, and opioids. These populations need to be a focus of tobacco control policies and interventions moving forward, so that “no man is left behind” in our efforts to reduce smoking prevalence. In this manner equity is the focus, not just equality. Several key highlights for the meeting are: Wednesday, March 8, 2017 5:00 p.m.-6:00 p.m. Keynote Presidential Symposium (Opening Session) Nicotine + Other Addictive Behaviors: Addressing the Added Complexities Across the Translational Continuum Speakers: Neal L. Benowitz MD, Chief, Division of Clinical Pharmacology, University of California San Francisco, USA; Ron Borland PhD, FASSA, Nigel Gray Distinguished Fellow in Cancer Prevention, The Cancer Council Victoria, Melbourne, Australia; Joanna E. Cohen, PhD, Director, Institute for Global Tobacco Con- trol, Johns Hopkins Bloomberg School of Public, Baltimore, USA; Judith J. Prochaska, PhD, MPH, Associate Professor of Medicine, Department of Medicine, Stanford University, USA; Robert West, PhD, Professor of Health Psychology, University College London, UK Thursday, March 9, 2017 9:30 a.m.-10:30 a.m. Epidemiology and Public Health Themed Lecture and 2017 Doll-Wynder Award Recipient How to Think—Not Feel—About Tobacco Harm Reduction Kenneth E. Warner; Avedis Donabedian Distinguished University Professor of Public Health at the University of Michigan, USA. Thursday, March 9, 2017 2:00 p.m.-3:00 p.m. Pre-Clinical Theme Lecture Genetic Overlap Between Cigarette Smoking and Other Sub- stance Use Jacqueline Vink, Professor, Behavioral Science Institute, Devel- opmental Psychopathology, Radboud University Nijmegen, The Netherlands 3 SRNT 2017 · Florence, Italy Friday, March 10, 2017 9:00 a.m.-10:00 a.m. Clinical Theme Lecture Treatment of Patients With Tobacco Addiction: Improving Current Practice and Future Perspectives Professor Serena Tonstad, Head Physician, Preventive Cardiol- ogy section, Department of Endocrinology, Obesity and Preventive Medicine at Oslo University Hospital, Oslo, Norway and a Profes- sor, School of Public Health, Loma Linda University, Loma Linda, California. Friday, March 10, 2017 2:00 p.m.-3:00 p.m. Public Policy Theme Lecture Population Level Policies to Prevent Chronic Disease: Apply- ing Lessons From Nicotine and Tobacco Research Professor Linda Bauld, Professor of Health Policy, University of Stirling and Chair in Behavioral Research for Cancer Prevention, Cancer Research UK. President-elect of SRNT-Europe. Also, not to be missed: ● The Opening Reception on Wednesday, March 8, from 6:00 p.m.-7:30 p.m., which will include hors d’oeuvres. All attend- ees are welcome! ● The Opening Remarks and Awards Ceremony on Thursday, March 9, from 9:00 a.m.-9:30 a.m., with special recognition of SRNT awardees: Doll-Wynder Award Winner, Dr. Kenneth E. Warner; John Slade Award Winner, Dr. Martin Raw; and Jarvik-Russell Award Winner, Dr. Thomas Kirchner. ● The SRNT-Europe Members Meeting on Friday, March 10, 8:15 a.m.-8:45 a.m. ● The SRNT Members Meeting on Saturday, March 11, 8:15 a.m.-8:45 a.m. ● Gala Dinner hosted by the SRNT-Europe organization at the breathtaking Palazzo Borghese Florence on Friday, March 10, at 7:30 p.m. (available at an additional fee) ● New this year, SRNT is proud to announce ‘Meet-the-Editor’ sessions on Thursday, Friday, and Saturday during the Annual Meeting. We have created an opportunity for all participants to join editors of the leading tobacco and nicotine journals for conversation. Meet-the-Editor is a chance to put members of the editorial boards in the hotseat. Editor of each journal will host a face-to-face session with the participants of the meeting. The editor will be available to answer questions, hear ideas, and discuss any comments about the journals. All are welcome but graduate students and postdocs are particularly invited. For meeting attendees arriving early, there are 10 pre-conference workshops that will be held on Wednesday, March 8 (available at an additional fee). These include: ● SRNT-E Satellite Symposium: Comparing Regulations on Tobacco and Nicotine Products ● Novel Approaches to Implementing Tobacco Treatment Within Health Systems ● Is Nicotine Reduction Really a Viable Policy Option for To- bacco Control? ● Developing Evidence-Based Control Policies Targeting Water- pipe Tobacco Smoking: Time for Action 4 SRNT 2017 · Florence, Italy ● Working Globally to Support Rapid Learning for E-Cigarette Policy, Surveillance, and Policy Research ● Introduction to the Multiphase Optimization Strategy (Most) for Building More Effective, Efficient, Economical, and Scalable Behavioral and Biobehavioral Interventions ● FDA’s Population Health Standard: Balancing the Risks and Benefits in Regulatory Decision-Making ● Tobacco and Marijuana Co-Use in Adolescents and Young Adults ● Reducing the Impacts of Commercial Tobacco on Indig- enous Peoples: Best Practices for Engaging With Indigenous Peoples in Research ● What Does Our Tobacco Work Mean to Us? Translating Knowledge Through Art in Florence To follow, and as part of the general registration, please join us for the highly interactive Transdisciplinary Topical Discussions on Wednesday afternoon from 3:30 p.m.-4:45 p.m.: ● E-Health Smoking Cessation Interventions: Do They Really Work? ● NRT Bought Over the Counter: Are Gums and Patches Pos- sibly Not Effective in the Real World? ● Polysubstance Abuse: How to Treat Tobacco Alongside Other Addictions? ● Financial Incentives for Quitting Tobacco: An Effective and Ethical Approach? ● Making the Delivery of Tobacco Cessation Treatment Routine in Health Care Systems: What Are the Challenges? ● Vape Shops: Just Another Tobacco Product Retailer or a Smoking Cessation Service? ● How Do We Reduce Children’s Exposure to Second-Hand Tobacco Smoke Globally? For the first time in SRNT history, we have received over one thousand (!!!) abstracts submissions. Over the past six months, we have worked thoughtfully to create a timely and high-quality scientific program spanning the full breath of the nicotine and tobacco research field. Our early registration numbers indicate attendance may break another record, being even higher than last years’ meeting in Chicago. Back by popular demand, we are utiliz- ing nine consecutive rooms during podium presentations, so yes, we anticipate hearing it is hard to choose! We encourage you to attend sessions that stretch and expand your expertise, that you engage the company of your colleagues and seek out new connections, and importantly, that you enjoy the meeting and the true spirit of Italy! Kind Regards,
Load more

Recommended publications
  • Richard Doll
    2825 Obituary: Richard Doll Sir Richard Doll died earlier this year at age 92. The most The studies by Doll are bold and original science. They celebrated epidemiologist of the 20th century, Doll is best represent an important part of the foundation of modern known for his work on smoking and lung cancer, but there was population-based chronic disease research. By the early 1960s, so much more to his career. they constituted adequate evidence for public health action to His father was a general practitioner in London, and it was reduce tobacco smoking; in 1964, the U.S. Surgeon General’s from St. Thomas’s that Doll himself graduated in Medicine in first report on the adverse health consequences of tobacco was 1937. Even as a student, he showed his interest in epidemi- published. Today, they continue to remind us how carefully ologic and statistical tools, publishing on the need for proper crafted observational studies can advance scientific knowledge analysis and statistical testing in population studies of disease. regarding social and health issues that are not amenable to Later, Doll served in the Royal Medical Corps in France and experimentation on human populations. the Middle East throughout the Second World War. He began Asbestos. By the early 1930s, work in the asbestos products his research career at the Middlesex Hospital, studying industry in Britain was known to increase the risk of a occupational factors in the development of peptic ulceration. sometimes fatal nonmalignant pulmonary disease, termed He married Dr. Joan Faulkner around this time, and it was she asbestosis.
    [Show full text]
  • Date of Preparation October 1, 2020 Format of This CV: Committee On
    Date of Preparation October 1, 2020 Format of this CV: Committee on Appointments and Promotions Mailman School of Public Health, Columbia University Personal data Steven D. Stellman Birthdate: May 7, 1945 Birthplace: Toronto, Canada Citizenship: USA Academic appointments 1966-71 Teaching Fellow, Department of Chemistry, New York University 1971-73 Research Associate, Division of Biochemical Sciences, Princeton University 1973-74 Lecturer in Chemistry, University of Colorado, Denver 1978-82 Adjunct Associate Professor, Hunter College of the City University of New York, Depts. of Chemistry and Environmental Health Sciences 1979-82 Adjunct Associate Professor, Dept. of Research Medicine, University of Pennsylvania School of Medicine 1980-81 Adjunct Associate Professor, Dept. of Epidemiology, Cornell University School of Medicine 1981-94 Adjunct Associate Professor, Dept. of Community Medicine, Mt. Sinai School of Medicine, New York, NY 2000 - Professor of Clinical Epidemiology, Mailman School of Public Health, Columbia University; Assoc Chair, 2016- Education Ohio State University, B.Sc. 09/1964 to 06/1966, Chemistry. New York University, Ph.D. 09/1966 to 1971, Physical chemistry. Thesis title: Computer simulation of polymer conformation and conformational thermodynamics. Sponsor: Paul J. Gans, Ph.D. Citations: (1) Stellman SD, Froimowitz M, Gans PJ. J Computational Physics 1971; 7:179-182. (2) Stellman SD, Gans PJ. Macromolecules 1972; 5:516-526. (3) Stellman SD, Gans PJ. Macromolecules 1972; 5:720-729. Columbia University, M.P.H., 09/1990 to 06/1992, Executive MPH Program in Health Policy & Management Traineeships 1968-71 New York University, National Science Foundation Graduate Traineeship 1971-73 Princeton University, Post-doctoral fellow, Dept. of Biochemical Sciences Professional organizations and societies Society for Epidemiologic Research American College of Epidemiology American Public Health Association American Chemical Society American Society of Preventive Oncology Steven D.
    [Show full text]
  • AATS Graham Foundation
    AATS GRAHAM FOUNDATION 1973-2013 40YEARS OF SUPPORTING DRIVING LEADERSHIP, LEARNING AND INNOVATION IN THE PURSUIT OF EXCELLENCE 2013 ANNUAL REPORT Excellence! 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40 40
    [Show full text]
  • How Americans Learned About the Dangers of Cigarette Smoking In: the Case of Florida
    ATINER CONFERENCE PRESENTATION SERIES No: HUM2017-0002 ATINER’s Conference Paper Proceedings Series HUM2017-0002 Athens, 18 January 2017 How Americans Learned about the Dangers of Cigarette Smoking in: The Case of Florida Terry Parssinen Athens Institute for Education and Research 8 Valaoritou Street, Kolonaki, 10683 Athens, Greece ATINER’s conference paper proceedings series are circulated to promote dialogue among academic scholars. All papers of this series have been blind reviewed and accepted for presentation at one of ATINER’s annual conferences according to its acceptance policies (http://www.atiner.gr/acceptance). © All rights reserved by authors. 1 ATINER CONFERENCE PRESENTATION SERIES No: HUM2017-0002 ATINER’s Conference Paper Proceedings Series HUM2017-0002 Athens, 18 January 2017 ISSN: 2529-167X Terry Parssinen, PhD, Professor of History, University of Tampa,USA How Americans Learned about the Dangers of Cigarette Smoking in: The Case of Florida ABSTRACT The rate of cigarette smoking in America from the 1950s until the present has dropped from 44% to about 18%. The causes of this decline can be traced to concrete measures such as the prohibition of smoking in public areas, and the increase in cigarette taxes, making it more expensive for regular smokers to maintain their habits. However, underlying these changes has been a growing awareness of the health dangers from smoking. From 1950 until 1964, medical and scientific researchers announced the results of experiments and survey data that showed a strong positive correlation between cigarette smoking and various diseases, beginning with lung cancer, but eventually including COPD, heart disease, and other forms of cancer.
    [Show full text]
  • The Adverse Health Effects of Smoking and the Tobacco Industry’S Efforts to Limit Tobacco Control
    THE ADVERSE HEALTH EFFECTS OF SMOKING AND THE TOBACCO INDUSTRY’S EFFORTS TO LIMIT TOBACCO CONTROL Prepared by: Jonathan M. Samet, MD, MS Director, USC Institute for Global Health Distinguished Professor and Flora L. Thornton Chair, Department of Preventive Medicine, Keck School of Medicine of USC University of Southern California 2001 North Soto Street, Suite 330A Los Angeles, California 90089-9239, USA Phone: +1 323 865 0803 Fax: +1 323 865 0854 Email: [email protected] 1 Table of Contents Summary ....................................................................................................................................................... 4 Professional Qualifications ........................................................................................................................... 6 Approach ....................................................................................................................................................... 9 Introduction and Context ............................................................................................................................ 10 Scientific approaches to smoking and health ......................................................................................... 11 Epidemiological research ........................................................................................................................ 14 Identifying causes of disease................................................................................................................... 15 The
    [Show full text]
  • Tesis Doctoral
    TESIS DOCTORAL EFECTIVIDAD DEL CONSEJO PARA DEJAR DE FUMAR COMBINADO CON LA DISCUSIÓN DETALLADA DE LOS RESULTADOS DE LA ESPIROMETRÍA POR PARTE DEL MÉDICO DE ATENCIÓN PRIMARIA SOBRE EL HÁBITO TABÁQUICO EN ADULTOS FUMADORES. Doctoranda: María del Mar Rodríguez Álvarez Director: Dr. Jordi Almirall Pujol DEPARTAMENTO DE MEDICINA Barcelona, 2012 DEPARTAMENTO DE MEDICINA Jordi Almirall Pujol, Profesor del Departamento de Medicina de la Universidad Autónoma de Barcelona, como Director, INFORMA: Que el trabajo titulado “EFECTIVIDAD DEL CONSEJO PARA DEJAR DE FUMAR COMBINADO CON LA DISCUSIÓN DETALLADA DE LOS RESULTADOS DE LA ESPIROMETRÍA POR PARTE DEL MÉDICO DE ATENCIÓN PRIMARIA SOBRE EL HÁBITO TABÁQUICO EN ADULTOS FUMADORES” realizado por María del Mar Rodríguez Álvarez, ha estado realizado bajo mi dirección y se encuentra en condiciones de ser leído y defendido como Tesis Doctoral delante del tribunal correspondiente de la Universidad Autónoma de Barcelona. Prof. Jordi Almirall Pujol Barcelona, 2012 3 A mi familia 5 Cuatro cosas es necesario extinguir en su principio: las deudas, el fuego, los enemigos y la enfermedad. Confucio (551-479 a. C.), filósofo chino 7 AGRADECIMIENTOS Esta tesis no hubiese estado posible sin la inestimable colaboración de muchas personas. En primer lugar querría agradecer la inestimable ayuda de mi director de tesis, el Dr. Jordi Almirall, que pacientemente ha seguido todo el proceso, haciendo las correcciones pertinentes, orientándome y guiándome en todo momento. Sin su colaboración y supervisión no habría sido posible realizar este proyecto. Al Dr. Torán, le he de agradecer su apoyo y confianza en este proyecto desde el inicio del mismo, facilitándome y poniendo a mi alcance todas las herramientas que he necesitado para sacar adelante el proyecto.
    [Show full text]
  • Landmarks in the History of Cancer Epidemiology Peter Greenwald and Barbara K
    Published OnlineFirst March 10, 2009; DOI: 10.1158/0008-5472.CAN-09-0416 Published Online First on March 10, 2009 as 10.1158/0008-5472.CAN-09-0416 AACR Centennial Series Landmarks in the History of Cancer Epidemiology Peter Greenwald and Barbara K. Dunn Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland Abstract Introduction The application of epidemiology to cancer prevention is Cancer epidemiology is the study of patterns and determinants relatively new, although observations of the potential causes of cancer risk, outcome, and control in healthy or diseased of cancer have been reported for more than 2,000 years. populations. Unlike the experimental nature of most clinical Cancer was generally considered incurable until the late 19th research, much of epidemiology is inherently observational, the century. Only with a refined understanding of the nature of study of people with and without disease (1, 2). One of cancer and strategies for cancer treatment could a systematic epidemiology’s initial roles in supporting cancer research was the approach to cancer prevention emerge. The 20th century saw collection of descriptive data on cancer incidence and mortality the elucidation of clues to cancer causation from observed to identify the health effects of cancer on society. As illustrated associations with population exposures to tobacco, diet, in Figs. 1 and 2, site-specific data on the mortality of women and environmental chemicals, and other exogenous factors. With men in the United States from cancer has been collected and repeated confirmation of such associations, researchers published since 1930. Understanding mortality trends for major entertained for the first time the possibility that cancer, like cancer types has focused research efforts and public policies in many of the infectious diseases of the time, might be areas that can affect public health.
    [Show full text]
  • A Smoking Gun:
    Why are tobacco companies allowed to spend $11/2 billion dollars per year to pro­ mote deadly products-with many of their messages intended for children? How can this situation be tolerated? How did it arise? What can we do about it? Can pro­ tection be achieved in a manner compati­ ble with free enterprise and individual freedom? How should the rights of smokers and nonsmokers be balanced? Must nonsmokers subsidize the cost of treating cigarette-induced disease? How much protection should nonsmokers have from drifting cigarette smoke? How can smokers escape from the grip of nicotine addiction and psychological dependence on smoking? Dr. Elizabeth Whelan addresses these and other important questions as she examines how the tobacco industry de­ veloped and thrived during the 20th century, creating an unprecedented chain of economic and physical dependence. She discusses the early launching of the Dr. Elizabeth M. Whelan is Executive Di­ cigarette, its initial rejection by those ac­ rector of the American Council on Science customed to the more "manly" pipe and and Health. She holds advanced degrees in cigar, and finally, its stellar success, result­ epidemiology and public health education ing in large part from an unparalleled from the Yale School of Medicine and the advertising blitz. Harvard School of Public Health, and has In many ways, the cigarette represents written extensively on a variety of topics just plain bad li.ick. By the time that the relating to the environment and public data on cigarette smoking and disease be­ health. Dr. Whelan resides in New York came conclusive in the 1950s, a substan­ City with her husband and daughter.
    [Show full text]
  • Four Decades of the German Tobacco Industry's Hidden Research
    242 Tobacco Control 2000;9:242–247 INDUSTRY WATCH Shameful science: four decades of the German tobacco industry’s hidden research on smoking and health The following presents the “best of the best” of smoking caused disease—they knew early on it annotations of over 600 tobacco industry did—but they were obsessed by the evidence documents that tell a nearly 40 year story of the that tobacco poisons released into the air could smoking and health research programme aVect the health of non-smokers; and they did sponsored by the members of the Association everything they could to deny, suppress, and of Cigarette Industries of Germany (the finally ignore the overwhelming evidence. “Verband”). Its members include the German and Austrian cigarette manufacturers as well as the transnational firms of Philip Morris (PM), The documents RJ Reynolds (RJR), and British American The Verband der Cigarettenindustrie (VdC) is Tobacco (BAT). the German trade association of cigarette The documents are part of some 33 million manufacturers whose members include the pages released as a result of legal agreements in German and Austrian tobacco companies the USA between state attorney generals and (Reemstma, Brinkmann, H van Landwyck, Austria Tabak, and three smaller companies), the American based tobacco companies. Virtu- as well as the German branches of three ally all are available on Internet websites. While transnational firms (PM, RJR, and BAT). It nearly all the annotated documents come from comprises five departments: industrial activi- PM and RJR and are in English, a large cache ties, trade issues, marketing, public aVairs, and of BAT documents on the Verband are held at the scientific department.
    [Show full text]
  • New Orleans March 11-14, 2020
    SRNT 26th ANNUAL MEETING new orleans maRCH 11-14, 2020 PROGRAM SRNT 2020 • New Orleans, Louisiana TABLE OF CONTENTS Abstract Reviewers.............................................................................................................................................10 Badges ............................................................................................................................................................... 21 Board of Directors & Leadership ........................................................................................................................ 22 Continuing Education Information ...................................................................................................................... 18 Exhibitors ............................................................................................................................................................ 28 Future Meetings.................................................................................................................................................. 23 Hotel Floor Plans ................................................................................................................................................ 30 Index–Author ...................................................................................................................................................... 85 Lunches .............................................................................................................................................................
    [Show full text]
  • The SAGE Encyclopedia of Cancer and Society
    The SAGE Encyclopedia of Cancer and Society Wynder, Ernst Contributors: Steven D. Stellman Editors: Graham A. Colditz Book Title: The SAGE Encyclopedia of Cancer and Society Chapter Title: "Wynder, Ernst" Pub. Date: 2015 Access Date: November 10, 2015 Publishing Company: SAGE Publications, Inc. City: Thousand Oaks, Print ISBN: 9781483345734 Online ISBN: 9781483345758 DOI: http://dx.doi.org/10.4135/9781483345758.n644 Print pages: 1327-1329 ©2015 SAGE Publications, Inc. All Rights Reserved. This PDF has been generated from SAGE knowledge. Please note that the pagination of the online version will vary from the pagination of the print book. Columbia University ©2015 SAGE Publications, Inc. All Rights Reserved. SAGE knowledge http://dx.doi.org/10.4135/9781483345758.n644 Ernst Wynder was a pioneer cancer researcher with notable achievements in tobacco and nutrition epidemiology that began in medical school, when he co-authored a seminal paper on smoking and lung cancer. He had a strong interest in prevention- oriented health education, especially for schoolchildren. Wynder began his career in an era when there was little scientific basis for prevention of chronic diseases like cancer and heart disease, and he played a significant role in developing the principles and practice of cancer control that still guide the field today. He was a tireless advocate of policies that integrated the roles of government, medical institutions, and individuals in using studies of disease causes to develop prevention and control strategies. He was an influential adviser on cancer policy to many U.S. government and international organizations, and he was founder and editor-in-chief of a major medical journal, Preventive Medicine, one of the first academic journals in the field.
    [Show full text]
  • Research on Smoking Behavior, 17
    U.S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE • Public Health Service • Alcohol, Drug Abuse, and Mental Health Administration Research on Smoking Behavior Editors: Murray E. Jarvik, M.D., Ph.D. Joseph W. Cullen, Ph.D. Ellen R. Gritz, Ph.D. Thomas M. Vogt, M.D., M.P.H. Louis Jolyon West, M.D. NIDA Research Monograph 17 December 1977 DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse Division of Research 5600 Fishers Lane Rockville, Maryland 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, D.C. 20402 Stock Number 017-024-00694-7 The NIDA Research Monograph series is prepared by the Division of Research of the National Institute on Drug Abuse. Its primary objective is to provide critical re views of research problem areas and techniques, the content of state-of-the-art conferences, integrative research reviews and significant original research. Its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisory Board Avram Goldstein, M.D. Addiction Research Foundation Palo Alto, California Jerome Jaffe, M.D. College of Physicians and Surgeons Columbia University New York Reese T. Jones, M.D. Langley Porter Neuropsychiatric Institute University of California San Francisco California William McGlothlin, Ph.D. Department of Psychology. UCLA Los Angeles, California Jack Mendelson, M.D. Alcohol and Drug Abuse Research Center Harvard Medical School McLean Hospital Belmont, Massachusetts Helen Nowlis, Ph.D. Office of Drug Education. DHEW Washington, D.C. Lee Robins, Ph.D.
    [Show full text]